Evaluation of Possible Effects of Hyoscine in Xylazine-Induced Fetal Death in Pregnant Rats

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 41

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJVS-18-2_001

تاریخ نمایه سازی: 8 خرداد 1403

Abstract:

Although xylazine is widely used in domestic animals as a sedative, analgesic, and muscle relaxant, its side effects on the uterus prevent its utilization in pregnant animals or in embryo transfer. Although the effects of xylazine on increasing uterine contractions have been confirmed, no reliable report of fetal death due to xylazine administration has been published. Hyoscine is an anticholinergic medication that has antimuscarinic and antispasmodic effects in the uterine tissue of pregnant cattle during in vitro studies, therefore, we investigated if administration of xylazine in the last third of pregnancy could increase fetal death and if hyoscine could prevent its adverse effects. Twenty adult female rats, after mating with four adult male rats and confirming pregnancy, were randomly divided into two equal control and treatment groups. On the ۱۸th day of pregnancy, the number of fetuses per rat was determined using ultrasonography. Rats in the treatment group received hyoscine (۱ mg/kg, intraperitoneally) for ۳ days. Subsequently, all rats were administered xylazine (۱۰ mg/kg, intraperitoneally) for ۳ days. On the ۲۱st day of pregnancy, the number of living and dead fetuses was counted after laparotomy. Also, the weight and dimensions of the fetuses were measured. The results showed that although more fetuses lost their lives in the treatment group compared to the control group, the statistical difference in the percentage of fetal mortality in the two groups was not significant (p  ۰.۰۵). In addition, the comparison of the mean weight, body length, and body width of living and dead fetuses in both groups showed that there was no statistically significant difference between these groups (p  ۰.۰۵). It could be concluded that maternal xylazine intake in rats could cause about ۱۸-۲۵% of fetal mortality. However, the use of hyoscine to prevent fetal death induced by xylazine is not recommended.

Authors

Mona Zohani-Ghayeni

Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Siamak Kazemi-Darabadi

Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Abolfazl Hajibemani

Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Ghasem Akbari

Department of Basic Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Zeiler GE. A review of clinical approaches to antagonism of ...
  • Perez R, Garcia M, Arias P, Gallardo M, Valenzuela S, ...
  • Piccinno M, Rizzo A, Mutinati M, D'Onghia G, Sciorsci RL. ...
  • Sakamoto H, Misumi K, Nakama M, AOKI Y. The effects ...
  • Tsatsaris V, Cabrol D, Carbonne B. Pharmacokinetics of tocolytic agents. ...
  • Jang HY, Lee KM, Park YS, Moon MJ, Hahn WB, ...
  • Kido A, Togashi K, Hatayama H, Nakayama T, Yamamoto A, ...
  • Sciorsci RL, Piccinno M, Rizzo A. Scopolamine butylbromide decreases the ...
  • Kirberger RM, Bester EG, Schulman ML, van Rensburg IJ, Hartman ...
  • Inaba T, Inoue A. Use of echography in rats for ...
  • Gomar A, Hosseini A, Mirazi N, Gomar M. Effect of ...
  • Enginar N, Nurten A, Türkmen AZ, Çağla B. Scopolamine-induced convulsions ...
  • Stickrod G. Ketamine/xylazine anesthesia in the pregnant rat. Journal of ...
  • Knight AP. Xylazine. Journal of American Veterinary Medical Association. ۱۹۸۰; ...
  • LeBlanc MM, Hubbell JA, Smith HC. The effects of xylazine ...
  • Yasuda K, Sumi G, Kanamori C, Nakajima T, Tsuzuki T, ...
  • Taneike T, Kitazawa T, Funakura H, Asanuma K, Tsuji S, ...
  • Kitazawa T, Hirama R, Masunaga K, Nakamura T, Asakawa K, ...
  • Hodgson DS, Dunlop CI, Chapman PL, Smith JA. Cardiopulmonary effects ...
  • J Eesa M. The clinical evaluation of the effect of ...
  • Blanchard TL, Thompson JA, Brinsko SP, Varner DD, Love CC, ...
  • Holden JE, Schwartz EJ, Proudfit HK. Microinjection of morphine in ...
  • Peričić D, Švob D, Jazvinšćak Jembrek M, Mirković Kos K. ...
  • Paris A, Philipp M, Tonner PH, Steinfath M, Lohse M, ...
  • Prieto M, Gómez FM, Teresa Giralt M. Effects of acute, ...
  • Finn DP, Hudson AL, Kinoshita H, Coventry TL, Jessop DS, ...
  • Marnet PG, Garcia-Villar R, Laurentie MP, Toutain PL. In vivo ...
  • Rodriguez-Martinez H, McKenna D, Weston PG, Gustafsson BK, Whitmore HL. ...
  • Pirnik Z, Jezova D, Mikkelsen JD, Kiss A. Xylazine activates ...
  • Ko JC, Smith BE, Hsu WH. Xylazine enhances porcine myometrial ...
  • Gibbs III HM, Troedsson MH. Effect of acepromazine, detomidine, and ...
  • De Lille AJ, Silvers ML, Cadario ME, Tran TQ, Cage ...
  • Ko JC, Hsu WH, Evans LE. The effects of xylazine ...
  • Thaete LG, Levin SI, Dudley AT. Impact of anaesthetics and ...
  • Waldvogel D, Bleul U. Effect of xylazine, isoxsuprine, and lidocaine ...
  • Toma VA, Filip A, Farcas A, Mirescu C, Rosioru C. ...
  • Tytgat GN. Hyoscine butylbromide. Drugs. ۲۰۰۷; ۶۷(۹): ۱۳۴۳-۱۳۵۷ ...
  • Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in ...
  • Sato Y, Hotta H, Nakayama H, Suzuki H. Sympathetic and ...
  • Braun U, Gansohr B, Hässig M. Ultrasonographic evaluation of reticular ...
  • Rizzo A, Gazza C, Silvestre A, Maresca L, Sciorsci RL. ...
  • Romański KW. Characteristics of phase ۳-like activity and rebound excitation ...
  • نمایش کامل مراجع